ROTHBLATT MARTINE A bought UTHR
September 9, 2025 · Form 4 insider transaction
ROTHBLATT MARTINE A bought 8,000 shares of United Therapeutics Corporation at $120.26 per share, a transaction worth $962.1K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
8,000
Price
$120.26
Total value
$962.1K
InsiderROTHBLATT MARTINE A
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 9, 2025
Filing dateSeptember 10, 2025
Shares owned after8,130
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on May 2, 2025. This plan will continue until the earlier of: (a) exhaustion of a tranche of 294,000 stock options that expire March 15, 2026; or (b) December 31, 2025.